What is he best known for?
The fields of study he is best known for:
- Enzyme
- Biochemistry
- Cancer
His main research concerns Carcinogen, Biochemistry, Mutagen, Chromatography and DNA.
His Carcinogen research incorporates elements of Ochratoxin A, Adduct, Stereochemistry and DNA damage.
His study in Heterocyclic compound extends to Biochemistry with its themes.
The various areas that Robert J. Turesky examines in his Mutagen study include Pyridine, Phase II Detoxification and Sequence analysis.
His Chromatography research is multidisciplinary, incorporating perspectives in Quinoline, Quinoxaline and Amine gas treating.
In his study, which falls under the umbrella issue of DNA, Cytosol and Organic chemistry is strongly linked to Metabolism.
His most cited work include:
- Aristolochic acid and the etiology of endemic (Balkan) nephropathy (422 citations)
- Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon (310 citations)
- Aristolochic acid-associated urothelial cancer in Taiwan (261 citations)
What are the main themes of his work throughout his whole career to date?
Robert J. Turesky spends much of his time researching Carcinogen, Biochemistry, DNA, Adduct and Chromatography.
His research in Carcinogen intersects with topics in Molecular biology, Aromatic amine, DNA damage and Stereochemistry.
His study looks at the relationship between Biochemistry and fields such as Quinoxaline, as well as how they intersect with chemical problems.
The study incorporates disciplines such as Tobacco smoke, Nucleotide and Genotoxicity in addition to DNA.
In his study, Human serum albumin is strongly linked to Serum albumin, which falls under the umbrella field of Adduct.
His research investigates the link between 2-Amino-1-methyl-6-phenylimidazopyridine and topics such as Pyridine that cross with problems in Indole test.
He most often published in these fields:
- Carcinogen (58.05%)
- Biochemistry (49.15%)
- DNA (27.12%)
What were the highlights of his more recent work (between 2016-2021)?
- Carcinogen (58.05%)
- DNA (27.12%)
- Biochemistry (49.15%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Carcinogen, DNA, Biochemistry, DNA damage and Adduct.
Robert J. Turesky is involved in the study of Carcinogen that focuses on DNA adduct in particular.
His DNA research includes themes of Molecular biology, Human genome, Nucleotide and Mass spectrometry.
His study in Biochemistry is interdisciplinary in nature, drawing from both Tandem mass spectrometry and Orbitrap.
The various areas that Robert J. Turesky examines in his Adduct study include Selected ion monitoring, Nitrogen, Mechanism of action, Aromatic amine and 2-Amino-1-methyl-6-phenylimidazopyridine.
He has researched Aromatic amine in several fields, including Metabolite and Stereochemistry.
Between 2016 and 2021, his most popular works were:
- Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy. (58 citations)
- Biomonitoring Human Albumin Adducts: The Past, the Present, and the Future. (38 citations)
- Data-Independent Mass Spectrometry Approach for Screening and Identification of DNA Adducts (19 citations)
In his most recent research, the most cited papers focused on:
Robert J. Turesky mainly investigates Carcinogen, DNA, Molecular biology, Adduct and DNA adduct.
His Carcinogen research is multidisciplinary, relying on both Bladder cancer, Food science, Aflatoxin, Nitrite and Serum albumin.
His DNA research is multidisciplinary, incorporating elements of Environmental chemistry and Tandem mass spectrometry, Mass spectrometry.
His Mass spectrometry research incorporates elements of Oxidative stress, Biochemistry and Genome.
He is studying Melanin, which is a component of Biochemistry.
His DNA adduct study combines topics in areas such as genomic DNA, Tobacco smoke, Gas chromatography, Biomarker and Aromatic amine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
